Skip to main content
AdTab 112 mg - Chewable tablet
  • Lotilaner
  • Valid
Authorised in these countries:
  • Denmark
  • Ireland
  • Austria
  • Belgium
  • Bulgaria
  • Cyprus
  • Czechia
  • Germany
  • Estonia
  • Spain
  • Finland
  • France
  • Greece
  • Croatia
  • Hungary
  • Iceland
  • Italy
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Latvia
  • Malta
  • United Kingdom (Northern Ireland)
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Sweden
  • Slovenia
  • Slovakia

Product identification

Medicine name:
AdTab 112 mg - Chewable tablet
Active substance and strength:
  • Lotilaner
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53BE04
Authorisation number:
This information is not available for this product.
Product identification number:
  • E8AE82D8-1BBC-DE6C-E053-2F2A11AC487D
Permanent identification number:
  • 600000099777

Product details

Pharmaceutical form:
  • Chewable tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog

Availability

Package description:
  • Packaging:Blister (Alu/Alu), Package_size:3 tablets
  • Packaging:Blister (Alu/Alu), Package_size:1 tablet
Manufacturing sites for batch release:
This information is not available for this product.
Source wholesaler:
This information is not available for this product.
Destination wholesaler:
This information is not available for this product.

Authorisation details

Authorisation status:
  • Valid
Authorisation procedure type:
  • Marketing Authorisation
Procedure number:
  • EMEA/V/C/006030
Date of authorisation status change:
Authorisation country:
This information is not available for this product.
Responsible authority:
  • European Commission
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation issued:
Reference member state:
This information is not available for this product.
Concerned member states:
This information is not available for this product.
Reference product identifier:
This information is not available for this product.
Source product identifier:
This information is not available for this product.

Additional information

To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet

Documents

First published:
Last updated:
First published:
Last updated:
First published:
Last updated:
First published:
Last updated:
First published:
Last updated:
First published:
Last updated:
First published:
Last updated:
First published:
Last updated:
First published:
Last updated:
First published:
Last updated:
First published:
Last updated:
First published:
Last updated:
First published:
Last updated:
First published:
Last updated:
First published:
Last updated:
First published:
Last updated:
First published:
Last updated:
First published:
Last updated:
First published:
Last updated:
First published:
Last updated:
First published:
Last updated:
First published:
Last updated:
First published:
Last updated:
First published:
Last updated:
First published:
Last updated:
First published:
Last updated:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."